SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 187.65+0.9%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (18)9/5/1996 11:26:00 PM
From: Michael H. Dragon   of 1686
 
Harold,I think that if you are looking for another established biotech
to get into you should take a good look at Genzyme. They have been
beating the streets earning estimates just about every quarter.They
should be getting approval in Japan in the next 6 months to market
their product for Gaucher Disease. Also they recently got FDA approval
for their product used to prevent adhesions and the FDA gave them
approval to market this product for a wider range of surgeries than
the street expected they would get. Still the stock has underperformed
but I think it's only a matter of time before it starts getting priced
at a much higher multiple.They have an excellent management team an
a strong pipeline of products. Take a look at it and let me know what
you think.I've been long on both bgen &

genz for about 5 years now. Good Luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News